Tag

Cancer Vaccines

All articles tagged with #cancer vaccines

health-and-biotech3 days ago•18 min saved

NIH Launches Public-Private Cancer Vaccine Initiative to Accelerate Personalized Treatments

The National Institutes of Health (NIH) is launching a public-private partnership in December to accelerate the development of personalized cancer vaccines. This initiative, modeled after the rapid success of COVID-19 vaccines, aims to reduce the timeline for bringing new treatments to market from 8-15 years to 7-10 years. The program will initially focus on pancreatic, liver, and colorectal cancers, as well as pediatric tumors. The announcement triggered a significant rally in vaccine-related stocks, with Novavax and Moderna leading gains, driven by the promise of faster clinical trials and reduced R&D costs for participating companies.

via Yahoo Finance|

#biotech-stocks #cancer-vaccines #clinical-trials

biotechnology3 days ago•17 min saved

Moderna Surges to Four-Year High as NIH Launches National Cancer Vaccine Initiative

Moderna shares jumped 14% to a four-year high after reports of a new NIH-led national initiative to accelerate cancer vaccine development. The move follows positive Phase 3 results for the company's melanoma therapy and mirrors a similar UK program launched in 2024.

via Yahoo Finance|

#biotechnology #cancer-vaccines #moderna

health14 days ago•6 min saved

Personalized mRNA vaccines show promise in melanoma trials

Moderna and Merck reported positive Phase 3 results for a personalized mRNA cancer vaccine, intismeran autogene, in melanoma patients. While the therapy remains investigational, early data suggests it reduces recurrence when combined with immunotherapy. Experts highlight the potential for personalized treatments across various cancers, though access and cost remain significant hurdles.

via New York Post|

#cancer-vaccines #clinical-trials #health

health-and-biotech21 days ago•14 min saved

Cancer Vaccine Market Set to Hit 36% CAGR as mRNA Breakthroughs Expand Beyond Melanoma

The global cancer vaccine market, valued at $335 million in 2025, is projected to grow at a 36% compound annual rate through 2036. This expansion is driven by the recent Phase 3 success of Moderna and Merck’s personalized mRNA vaccine for melanoma, alongside a broadening pipeline targeting lung, prostate, and pancreatic cancers. While the US dominates current sales, analysts note a persistent gap between early immune responses and late-stage clinical efficacy.

via PR Newswire|

#cancer-vaccines #health-and-biotech #immunotherapy

health1 month ago•204 min saved

Breakthrough Cancer Vaccine Gains Ground, but Misinformation Could Stall It

A personalized mRNA cancer vaccine from Moderna and Merck reduced melanoma recurrence when combined with Keytruda in a late-stage trial, signaling a potential new era in cancer prevention and treatment, but wide-spread misinformation about mRNA technology—including the ‘turbo cancer’ narrative—could undermine public trust and slow adoption of these advances.

via CNN|

#cancer-vaccines #health #immunotherapy

health2 months ago•201 min saved

Vaccines aim to stop Lynch syndrome–driven colon cancer before it starts

Researchers are testing vaccines designed to train the immune system to recognize and destroy precancerous Lynch syndrome–driven cells, with early trials showing reduced precancerous polyps and polyp-free colonoscopies in some participants. Several vaccines are in development (Nouscom in the US/UK, Moderna via Oxford, ImmunityBio) aiming to prevent colorectal cancer before it starts, potentially reducing the need for yearly colonoscopies for high-risk individuals. Results are early but promising for those with inherited cancer risk and their families.

via CNN|

#cancer-vaccines #colon-cancer #genetics

health5 months ago•14 min saved

Personalized mRNA Cancer Vaccines Show Promise Amid Turbulence

A small Memorial Sloan Kettering study finds a patient-specific mRNA vaccine for pancreatic cancer can provoke strong immune responses and deliver long-term survivors, despite a turbulent year of funding and public skepticism around mRNA. Eight of 16 patients had a meaningful immune response and seven are alive six years after the trial; larger multisite trials and industry backing are advancing the approach, which also includes non-personalized, off-the-shelf vaccines aiming to trigger broader anti-tumor immunity.

via WRAL|

#cancer-vaccines #health #immunotherapy

health6 months ago•12 min saved

Misinformation could slow the next wave of cancer vaccines

Researchers are advancing personalized mRNA cancer vaccines that may transform cancer care, but the spread of misinformation—notably the turbo cancer myth tying COVID-19 vaccines to aggressive cancers—could erode public trust and hinder adoption; proactive, transparent science communication and clinician conversations are essential to realizing these vaccines’ potential.

via The Conversation|

#cancer-vaccines #health #health-communication

health8 months ago•6 min saved

Global Expert Alliance Sets Course to Accelerate Therapeutic Cancer Vaccines

More than 50 leading cancer vaccine researchers convene a two-day global think tank—organized by the Cancer Vaccine Coalition and AACR—to align priorities and accelerate development and access to therapeutic cancer vaccines through practical strategies, AI-driven antigen prediction, and coordinated funding and regulatory pathways, with trials across glioblastoma, melanoma, pancreatic, breast, ovarian and liver cancers and support from HSBC Innovation Banking, Northwest Biotherapeutics, Pfizer, and Anixa Biosciences.

via PR Newswire|

#cancer-research #cancer-vaccines #clinical-trials

health1 year ago•2 min saved

Debate Over mRNA Vaccine Funding and Future in Public Health

The U.S. Department of Health and Human Services is ending significant funding for mRNA vaccines for infectious diseases, raising concerns among cancer researchers that broader hostility towards mRNA technology could hinder the development of promising cancer vaccines, although current oncology research appears unaffected.

via statnews.com|

#biotech #cancer-vaccines #health

health-cancer-research2 years ago•3 min saved

"Pink Eraser Project Accelerates Breast Cancer Vaccine Development"

Former NBC correspondent Kristen Dahlgren left her dream job to launch the Pink Eraser Project, aiming to accelerate breast cancer vaccines after learning about promising research from Dr. Nora Disis. The project seeks to streamline funding and collaboration to bring safe and affordable breast cancer vaccines to fruition, potentially changing the landscape of breast cancer treatment worldwide.

via Maria Shriver's Sunday Paper|

#breast-cancer #cancer-research #cancer-vaccines

health-science2 years ago•1 min saved

"Putin: Russia Nearing Breakthrough in Cancer Vaccine Development"

Russian President Vladimir Putin announced that the country is on the verge of creating cancer vaccines and immunomodulatory drugs of a new generation, expressing hope for their effective use in individual therapy. While he did not specify the targeted cancer types or methods, several countries and companies are already working on cancer vaccines, with some showing promising results in clinical trials. This announcement comes as Russia previously developed the Sputnik V vaccine against COVID-19, facing public reluctance domestically despite being sold to other countries.

via Fox News|

#cancer-vaccines #health-science #immunotherapy

health-science2 years ago•1 min saved

"Putin Announces Russia's Progress in Cancer Vaccine Development"

Russian President Vladimir Putin announced that Russian scientists are on the verge of creating cancer vaccines and immunomodulatory drugs of a new generation, which could soon be used for individual therapy. While specific details were not provided, several countries and companies are already working on cancer vaccines, with some showing promising results in clinical trials. This announcement comes as Russia previously developed the Sputnik V vaccine against COVID-19 and faced public reluctance to get vaccinated domestically.

via Reuters|

#cancer-vaccines #future-technologies #health-science

health-science2 years ago•1 min saved

"Putin Announces Russia's Progress in Cancer Vaccine Development"

Russian President Putin announced that the country's scientists are on the verge of creating cancer vaccines and new-generation immunomodulatory drugs, expressing hope for their effective use in individual therapy. While not specifying the targeted cancer types or the mechanisms involved, Putin's statement aligns with global efforts in personalized cancer treatments, including ongoing trials by UK-based BioNTech and developments by pharmaceutical companies like Moderna and Merck & Co. This announcement comes in the wake of Russia's successful development and international distribution of the Sputnik V COVID-19 vaccine, as the country continues to advance its contributions to medical innovation.

via Yahoo News|

#cancer-vaccines #future-technologies #health-science

health-and-biotech2 years ago•3 min saved

"Evaxion's Breakthrough: AI-Driven Cancer Vaccine Boosts Stock by 30%"

Evaxion Biotech is leveraging AI-Immunology™ to develop tailored cancer vaccines targeting Endogenous Retroviruses (ERVs), an untapped source of tumor antigens, with the goal of providing treatment solutions to cancer patients unresponsive to conventional immunotherapy. The company aims to generate Proof-of-Concept data by the second half of 2024 and has presented recent insights at the American Society of Hematology Annual Meeting. ERVs, remnants of ancient viruses overexpressed in cancer, are promising targets for cancer vaccines, and AI-Immunology™ plays a crucial role in identifying therapeutically relevant ERV tumor antigens from genomic patient tumor data. Evaxion's AI-Immunology™ platform offers a scalable and adaptable approach to vaccine discovery for infectious diseases and cancers, revolutionizing the landscape of immunotherapy with personalized medicine.

via Yahoo Finance|

#ai-immunology #cancer-vaccines #ervs